Metabolites · 2023 · 14 citations · 36 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryMolecular PharmacologyComputational Drug DiscoveryEnzyme InhibitionMolecular DockingProtein-ligand DockingStructure-activity Relationship AnalysisVirtual ScreeningAllosteric Drug DiscoveryAllosteric Site IdentificationAllosteric Site TargetingDocking-based Drug DesignMolecular Docking AnalysisMolecular Docking Of InhibitorsNeglected Tropical Disease MedicinesTherapeutic Target Identification
Schistosomiasis is a neglected tropical disease with a significant socioeconomic impact. It is caused by several species of blood trematodes from the genus Schistosoma, with S. mansoni being the most prevalent. Praziquantel (PZQ) is the only drug available for treatment, but it is vulnerable to drug resistance and ineffective in the juvenile stage. Therefore, identifying new treatments is crucial. SmHDAC8 is a promising therapeutic target, and a new allosteric site was discovered, providing the opportunity for the identification of a new class of inhibitors. In this study, molecular docking was used to screen 13,257 phytochemicals from 80 Saudi medicinal plants for inhibitory activity on the SmHDAC8 allosteric site. Nine compounds with better docking scores than the reference were identified, and four of them (LTS0233470, LTS0020703, LTS0033093, and LTS0028823) exhibited promising results in ADMET analysis and molecular dynamics simulation. These compounds should be further explored experimentally as potential allosteric inhibitors of SmHDAC8.
36
Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters
K. J. Bowers, David E. Chow, Huafeng Xu et al. · 2006 · 1.7K citations
Expression profile of class I histone deacetylases in human cancer tissues
Masamune Nakagawa, Yoshinao Oda, Takashi Eguchi et al. · Oncology Reports · 2007 · 341 citations · Full text